MTIP Welcomes Two New Board Members

MTIP appoints Daniela Nienstedt and Benjamin Gilgen to Board of Directors

News

MTIP Leads Growth Financing Round for Hexarad

MTIP is pleased to announce MTIP Fund II’s ninth platform investment in Hexarad, leading the €13 million growth round with reinvestment from existing shareholders.

News

Dealroom Report: Growth Equity in European Healthtech

In our latest healthtech report, prepared in collaboration with Dealroom.co, we highlight key trends and opportunities in the European healthtech space, primarily covering the growth stage.

Blog

MTIP is now a Certified B Corporation™!

We are proud to announce that MTIP has been certified as a B Corporation with a score of 107.5.

News

MTIP Invests $15 Million in Caresyntax

MTIP invested $15 million to accelerate Caresyntax's commercial growth and to expand its data-driven surgery platform.

News

Sailing the Waves of the Basel Healthtech Conference: A Recap and Reflection

As we conclude the Basel Healthtech Conference, we reflect on the incredible moments, insightful discussions, and transformative ideas that shaped this extraordinary event!

Blog

Empowering Women's Health: Navigating the Femtech Sector

Our new interactive guide sheds light on investment and innovation trends in the Femtech sector.

Blog

The Potential of AI in Healthcare & Data Science

Gerry Liaropoulos (Director of Data Science and Bioinformatics at Intelligencia.ai) and Jan Przybylowicz (Investment Analyst at MTIP) speak to Anja-Vanessa Peter (Communication Manager at MTIP) about the inner workings of ChatGPT and implications for the world of medicine and data science.

Blog

Employee Wellbeing at MTIP

We at MTIP understand that the physical and mental wellness of our team members has a direct impact on our overall performance.

Blog

Dealroom Report: Tooling the Physicians of the Future

European startups addressing clinical capacity bottlenecks

Blog

MTIP Office Featured in Swiss Office Blog

The MTIP office in Basel is featured in the Swiss office blog called “Büroblog Schweiz“ which provides information about interesting aspects of the office world.

News

Diversity, Equity, and Inclusion: The 3 Key Drivers for Success

At MTIP, we strive to create value for our investors and portfolio companies while remaining fully aware of our responsibility towards both society and the environment.

Blog

Growth Capital Decisions – An Interview with our Co-Founder & Managing Partner Dr. Christoph Kausch

What do growth capital investors look for? In the following interview, our Co-Founder and Managing Partner Dr. Christoph Kausch gives insight into growth capital decisions.

Blog

Rahel Hafner Receives Certificate in ESG Investing by CFA Institute

Congratulations to our Sustainability & Finance Manager Rahel Hafner for successfully passing the Certificate in ESG Investing by CFA Institute. Rahel is now fully equipped to guide MTIP and our portfolio companies in the fast-growing field of ESG investing in the best way possible.‍

News

What Makes a Great Founder/Investor Relationship?

Kai Eberhardt is the CEO and Co-Founder of our portfolio company Oviva. He talked to us about the founder/investor relationship and shared what he pays special attention to in this regard.

Blog

MTIP’s HealthCare Clinic 2022

At a nice and intimate setting in Basel, we invited our investors to our annual HealthCare Clinic last September 7 & 8.

News

Christoph Kausch selected by Real Deals as most influential for 2022

We are happy to share the news that Dr. Christoph Kausch, our Managing Partner at MTIP, made the list for Real Deals most influential for 2022.

News

MTIP leads €17 million financing round in virtual fertility clinic Apricity

We are delighted to announce MTIP Fund II’s newest investment in Apricity, UK’s leading virtual fertility clinic.

News

MTIP leads the €20 million growth financing round in LynxCare

We are delighted to announce MTIP Fund II’s sixth investment in LynxCare, the Belgian Health Data Scale-Up company.

News

Pioneering the use of machine learning algorithms to turbo-charge drug development

Novel therapy development is expensive, slow, and largely unsuccessful, making it critical to find new ways of bringing medicines to market. MTIP portfolio company, Intelligencia is helping pharmaceuticals and biotech to manage the risk of clinical development and optimize portfolio strategy.

Blog

The psychology of decision making

What makes a good investor? It’s a topic as old as investment itself, but will it evolve as Private Equity moves into new horizons such as digital medicine? Find out how MTIP approaches decision making for its investments in companies wanting to revolutionize healthcare.

Blog

Revolutionizing medical triage with artificial intelligence

Healthcare systems worldwide have been stretched to the limit by the COVID-19 pandemic, opening the door to AI driven revolutions in healthtech. The symptom checker, Mediktor, is leading the way.

Blog

MTIP Closes Second Healthtech Growth Fund Above Target With $250M of Commitments

‘Dark green’ fund aims to help healthtech innovators to become global leaders

News

Cynerio Now! – A new IoT cybersecurity solution for small hospitals and clinics

Cyberattacks and ransomware are real threats to all kinds of businesses. Recent years have shown that they do not spare the healthcare sector. The WannaCry ransomware attack in 2017 paralyzed United Kingdom’s National Health Service (NHS) for four days straight. This event served as a wake-up call to the industry. Healthcare organizations realized that they had to take appropriate actions to ensure their IT security and integrity stays intact, even when attacked.

Blog

MTIP invests in Mediktor

Investment led by MTIP enables the Spanish healthtech company Mediktor to keep on improving their elaborate technology and expand their international presence.

News

SFDR Art. 8 or Art. 9? What’s the difference?

It all started on the 10th of March of this year, the day on which the ESG – Sustainable Finance Disclosure Regulation (EU) 2919/2088 came into effect. In this blog post, we will be highlighting the differences between the various classifications of assets such as Art. 6, Art. 8, and Art. 9 of the Sustainable Finance Disclosure Regulation (SFDR).

Blog

MTIP participates in Oviva’s new $80m Series C funding

Ovivia raises $80 million financing round

News

MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence

Investment led by MTIP enables the company to reduce the risk of clinical research, improve R&D productivity, and accelerate scientific breakthroughs through artificial intelligence (AI) and natural language processing (NLP).

News

Private Equity 101: Part one – Glossary

Are you new to the healthtech space? Maybe even the investment sector? Was that a “Yes”? Don’t worry, in the beginning, everything seems overwhelming and all the definitions and keywords are tricky to keep in mind. But there is always hope…

Blog

Leading brands revolutionize care journeys with Lumeon

Historically patient care journeys in healthcare facilities such as hospitals or clinics have often been described as fragmented. Lumeon has developed a flexible platform and series of solutions that address this problem. Learn more about the company in our latest blog post.

Blog

Trialbee – our hero in patient matching and recruiting for clinical trials

How can you keep the engagement rate of patients in clinical trials at a high level? Our portfolio company Trialbee has developed a solution for this problem with their patient recruitment and engagement platform. Learn more about the company in our latest blog post.

Blog

Digital healthcare: patient-first?

We have been collaborating with Dealroom.co, a data provider on startups, growth companies and tech ecosystems around the globe and INKEF Capital, a venture capital firm based in Amsterdam on our "Digital Healthcare Report". Today we are happy to present our results.

News

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations

Blog

MTIP Drives Strategic Growth for Mediktor through Sensely Acquisition

Mediktor, a leading provider of AI-powered tools for medical triage and pre-diagnosis, is acquiring Sensely, a cutting-edge virtual assistant that specializes in patient engagement and healthcare navigation.

News